import { serve } from "https://deno.land/std@0.168.0/http/server.ts";
import { createClient } from "https://esm.sh/@supabase/supabase-js@2";
import { corsHeaders, validateBodySize, errorResponse } from "../_shared/cors.ts";
import { requireAdmin } from "../_shared/auth.ts";

import { guardSeedFunction } from "../_shared/seedGuard.ts";
serve(async (req) => {
  if (req.method === 'OPTIONS') {
    return new Response(null, { headers: corsHeaders });
  }



  const seedGuard = await guardSeedFunction(req);
  if (seedGuard) return seedGuard;
  try {
    const authResult = await requireAdmin(req);
    if (authResult instanceof Response) return authResult;

    const supabaseUrl = Deno.env.get('SUPABASE_URL')!;
    const supabaseKey = Deno.env.get('SUPABASE_SERVICE_ROLE_KEY')!;
    const supabase = createClient(supabaseUrl, supabaseKey);

    const articles = [
      // DIABETO 18+ ARTICLES (5)
      {
        title: "The Complete Guide to Alcohol and Type 1 Diabetes",
        slug: "alcohol-and-type-1-diabetes-complete-guide",
        excerpt: "Everything you need to know about drinking alcohol safely with T1D, from delayed lows to insulin adjustments and harm reduction strategies.",
        content: {
          sections: [
            {
              heading: "Understanding How Alcohol Affects Blood Sugar",
              text: "Alcohol has a unique and somewhat paradoxical effect on blood sugar for people with Type 1 diabetes. While many alcoholic beverages contain carbohydrates that would normally raise blood sugar, alcohol itself suppresses the liver's ability to release stored glucose (glycogen). This creates a complex situation where you might see an initial spike from carbs, followed by a prolonged risk of hypoglycemia that can last 12-24 hours after drinking."
            },
            {
              heading: "The Science Behind Delayed Lows",
              text: "Your liver is responsible for producing glucose through a process called gluconeogenesis and releasing stored glucose (glycogenolysis). When you consume alcohol, your liver prioritizes metabolizing the alcohol over these glucose-producing processes. This means your normal safety net—the liver releasing glucose when blood sugar drops—is effectively disabled. This is why delayed lows can occur 6-12 hours after your last drink, often during sleep."
            },
            {
              heading: "Practical Strategies for Safer Drinking",
              text: "Pre-drinking preparation: Eat a meal containing protein and fat before drinking. This slows alcohol absorption and provides a glucose buffer. During drinking: Check your CGM frequently. Choose lower-carb options when possible (dry wine, spirits with zero-calorie mixers). Alternate alcoholic drinks with water. Before bed: Eat a snack containing protein and carbs. Set your basal rate 20-30% lower for 8 hours. Tell someone to check on you. Set a 3am alarm to verify blood sugar."
            },
            {
              heading: "Different Drinks, Different Effects",
              text: "Beer: Contains 10-20g carbs per 12oz serving. Light beers have fewer carbs. Craft beers can have 30+ grams. Wine: Dry wines (red, white, champagne) have minimal carbs (3-4g per glass). Sweet wines can have 10+ grams. Spirits: Vodka, gin, whiskey, and tequila have zero carbs. Mixers are where the carbs hide—choose club soda over tonic water. Cocktails: Restaurant cocktails often contain hidden syrups and sugars. A margarita can have 30+ grams of carbs from the mix."
            },
            {
              heading: "Warning Signs and When to Get Help",
              text: "Alcohol impairs your ability to recognize hypoglycemia. Symptoms like confusion, shakiness, and slurred speech overlap with intoxication, making it easy to miss a low. Always wear medical identification when drinking. Tell at least one person about your diabetes. Know that glucagon may not work effectively while alcohol is in your system. If someone with diabetes appears excessively intoxicated, checking their blood sugar should be a first step."
            }
          ],
          medical_disclaimer: "This article is for educational purposes only and is not medical advice. Alcohol consumption carries health risks for everyone. Always consult with your endocrinologist about alcohol and your specific diabetes management plan."
        },
        featured_image_url: "https://images.unsplash.com/photo-1470337458703-46ad1756a187?w=800",
        category: "18+ Content",
        tags: ["alcohol", "harm reduction", "nightlife", "safety"],
        is_published: true,
        is_featured: true,
        reading_time_mins: 12,
        views: 4523,
        published_at: "2024-12-15T10:00:00Z"
      },
      {
        title: "Intimacy and Diabetes Technology: A Practical Guide",
        slug: "intimacy-diabetes-technology-practical-guide",
        excerpt: "Navigating CGMs, insulin pumps, and romantic relationships with confidence and practical strategies.",
        content: {
          sections: [
            {
              heading: "Introduction",
              text: "Diabetes technology has revolutionized blood sugar management, but it also adds visible devices to your body that can feel intrusive in intimate moments. This guide provides practical advice for navigating CGMs, insulin pumps, and romantic relationships. The goal is to help you feel confident while maintaining safe blood sugar management."
            },
            {
              heading: "CGM Placement Strategies",
              text: "Placement matters for intimacy. Back of the upper arm is generally the most out-of-the-way location for most activities. Lower back and hip areas work well but may be less accurate for some systems. Stomach and front-of-body placements are more likely to be bumped or compressed. Consider your sensor's accuracy in different locations and discuss with your endocrinologist about approved alternate sites."
            },
            {
              heading: "Managing Insulin Pumps During Intimacy",
              text: "Tubed pumps (Medtronic, Tandem): You can safely disconnect for up to 60 minutes. Keep the disconnect cap clean and nearby. Some people prefer the longer 32-inch tubing for more flexibility. Tubeless pumps (Omnipod): The pod stays on but can be placed on less intrusive locations like outer upper arm or lower back. The PDM/controller doesn't need to be nearby. General tip: It's completely okay to pause, disconnect, or adjust. Communicate with your partner about what works."
            },
            {
              heading: "Sex is Exercise: Plan Accordingly",
              text: "Physical intimacy affects blood sugar like any cardio activity. Many people find their blood sugar drops 40-70 points during active intimacy. Plan ahead: Eat a small snack if you're under 120 before intimacy. Keep glucose tabs on the nightstand. Wait at least 2 hours after bolusing for a meal—active insulin during physical activity increases low risk. Check blood sugar afterwards and be prepared to snack. Partners should know the signs of low blood sugar and what to do."
            },
            {
              heading: "Communication with Partners",
              text: "Talking about diabetes with romantic partners is essential for both safety and emotional connection. For new partners: Mention diabetes early and casually—'You might hear my CGM alarm, that's my glucose monitor.' Before physical intimacy, do a quick device tour. By the third date, share what to do if you go low. For established partners: Develop protocols together for overnight lows. Consider sharing CGM data via follow apps. Discuss how to handle interruptions from alarms gracefully."
            },
            {
              heading: "Common Concerns Addressed",
              text: "Will my devices get damaged? Modern CGMs and pods are designed to be durable and waterproof. Normal physical activity, including intimacy, won't damage them. What if an alarm goes off? Handle it calmly and quickly. A brief pause to check blood sugar doesn't need to be a mood killer. Communication and a sense of humor help. What about body image? Many people worry about visible devices. Remember that confidence comes from how you present yourself, not the absence of medical devices. The right partner will see your diabetes as a small part of who you are."
            }
          ],
          medical_disclaimer: "This article is for educational purposes. Discuss device placement and management with your healthcare provider."
        },
        featured_image_url: "https://images.unsplash.com/photo-1516589178581-6cd7833ae3b2?w=800",
        category: "18+ Content",
        tags: ["intimacy", "relationships", "CGM", "insulin pump", "communication"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 10,
        views: 3892,
        published_at: "2024-11-28T10:00:00Z"
      },
      {
        title: "Cannabis and Blood Sugar: What the Research Shows",
        slug: "cannabis-blood-sugar-research",
        excerpt: "A research-based look at how cannabis affects blood sugar, from munchies management to potential benefits.",
        content: {
          sections: [
            {
              heading: "Current State of Research",
              text: "Research on cannabis and diabetes is evolving. Some observational studies suggest cannabis users have lower rates of insulin resistance and smaller waist circumferences, but these are correlational, not causal. The endocannabinoid system does play a role in metabolism and appetite regulation. However, most research focuses on Type 2 diabetes, and T1D-specific studies are limited."
            },
            {
              heading: "CBD vs. THC: Different Effects",
              text: "THC (tetrahydrocannabinol): The psychoactive component. Commonly associated with increased appetite ('munchies'). No direct blood sugar effect has been consistently observed, but behavior changes (eating more) certainly affect glucose. CBD (cannabidiol): Non-psychoactive. Some animal studies suggest anti-inflammatory properties that could theoretically benefit diabetic complications, but human studies are limited. CBD does not appear to directly affect blood sugar in most users."
            },
            {
              heading: "Managing the Munchies",
              text: "The biggest practical concern for people with T1D using cannabis is the appetite stimulation that often accompanies THC use. Strategies that work: Stock low-carb snacks before using (cheese, nuts, vegetables). Plan for munchies by bolusing in advance if you know you'll eat. Choose strains lower in THC or balanced with CBD. Set limits on portions before you start."
            },
            {
              heading: "CGM Observations from Community Data",
              text: "Community members have tracked their glucose responses extensively. Common observations include: No direct blood sugar change from cannabis itself. Slight drops with sativa strains (possibly from increased activity). Spikes correlating with food consumed, not the cannabis. High doses can impair judgment about insulin dosing. Individual responses vary significantly—always track your own patterns."
            },
            {
              heading: "Risks and Harm Reduction",
              text: "Know the source: In legal states, products are tested for contaminants. Unregulated products carry additional risks. Start low: Especially with edibles, start with low doses and wait for effects. Don't adjust insulin while impaired: Make dosing decisions before or after use, not during peak effects. Have a plan: Tell someone about your diabetes, have glucose tabs accessible, keep your CGM charged. Avoid mixing with alcohol: Combining substances increases unpredictability."
            },
            {
              heading: "Legal Considerations",
              text: "Cannabis laws vary significantly by state and country. This article is for educational purposes in locations where use is legal for adults. Even in legal states, consumption may affect employment, insurance, and other legal matters."
            }
          ],
          medical_disclaimer: "This article is for educational purposes only. Cannabis is not FDA-approved for diabetes treatment. Consult with your healthcare provider about any substance use."
        },
        featured_image_url: "https://images.unsplash.com/photo-1542525187-f178ab0ef7f2?w=800",
        category: "18+ Content",
        tags: ["cannabis", "CBD", "THC", "munchies", "harm reduction"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 11,
        views: 2156,
        published_at: "2024-10-30T10:00:00Z"
      },
      {
        title: "Managing Diabetes at Parties and Social Events",
        slug: "diabetes-parties-social-events",
        excerpt: "Practical strategies for navigating parties, clubs, and social gatherings while keeping blood sugar in check.",
        content: {
          sections: [
            {
              heading: "Pre-Party Preparation",
              text: "Successful diabetes management at parties starts before you leave home. Eat a balanced meal with protein and fat 2-3 hours before the event. Check that your CGM is charged and working. Pack supplies: glucose tabs, backup receiver, medical ID, and a small snack. Let at least one friend know about your diabetes and where you keep glucose tabs. Set your CGM low alert slightly higher than usual (85 instead of 70)."
            },
            {
              heading: "Navigating Party Food",
              text: "Party food is notoriously hard to carb count. General strategies: Appetizers are usually lower carb than main courses (cheese, vegetables, meats). Dips often have hidden sugars—salsa and guacamole are usually safe. Fried foods absorb more slowly—expect delayed spikes. Pizza is a marathon, not a sprint—extended boluses help. Desserts vary wildly—when in doubt, overestimate. Don't be afraid to ask what's in something or to bring your own snacks."
            },
            {
              heading: "Dance Floor Considerations",
              text: "Dancing is cardio, which means blood sugar drops. Strategies for clubbing: Reduce your basal rate 30-40% starting when you arrive. Check your CGM every song change—make it a habit. Take breaks to eat or drink something with carbs. Keep glucose tabs in an accessible pocket, not a coat check bag. A small snack between songs can prevent lows. The combination of dancing, alcohol, and late hours is challenging—stay vigilant."
            },
            {
              heading: "The After-Party",
              text: "Post-party management is where many people slip up. Before bed: Eat something substantial with carbs and protein. Set your basal 25-30% lower for 8 hours if you've been drinking. Set an alarm to check blood sugar around 3am. Tell someone to check on you, especially after drinking. Don't skip breakfast—your liver needs to replenish glycogen stores. The next day: Expect unusual patterns. Stay well hydrated. Be gentle with yourself—one party won't ruin your A1C."
            },
            {
              heading: "Social Pressure and Boundaries",
              text: "Being pushed to eat or drink more than you want is common at parties. Scripts that work: 'I'm pacing myself.' 'I'm on medication that doesn't mix well with alcohol.' 'I'll have some in a bit.' You don't owe anyone an explanation. Checking your CGM openly is perfectly acceptable. If someone questions it, a simple 'it's my glucose monitor' is enough. Real friends will support your health needs."
            }
          ],
          medical_disclaimer: "This article is for educational purposes. Consult with your healthcare provider about managing diabetes in social situations."
        },
        featured_image_url: "https://images.unsplash.com/photo-1533174072545-7a4b6ad7a6c3?w=800",
        category: "18+ Content",
        tags: ["parties", "nightlife", "clubbing", "social events"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 9,
        views: 1834,
        published_at: "2024-09-22T10:00:00Z"
      },
      {
        title: "The Science of Delayed Alcohol Lows Explained",
        slug: "science-delayed-alcohol-lows",
        excerpt: "Understanding the biochemistry behind why lows can strike hours after drinking—and how to prevent them.",
        content: {
          sections: [
            {
              heading: "The Liver's Role in Blood Sugar",
              text: "Your liver is the central regulator of blood glucose. Between meals and during sleep, it maintains blood sugar through two processes: glycogenolysis (releasing stored glucose from glycogen) and gluconeogenesis (creating new glucose from amino acids and other substrates). For people with Type 1 diabetes, when insulin levels drop too low or glucose demand increases, this hepatic glucose output is the primary defense against hypoglycemia."
            },
            {
              heading: "How Alcohol Interferes",
              text: "When you consume alcohol, your liver prioritizes metabolizing it over other functions. Ethanol is converted to acetaldehyde and then to acetate through a process that occupies the liver's enzymatic machinery. This means: Glycogenolysis is suppressed—stored glucose can't be released. Gluconeogenesis is inhibited—new glucose can't be made efficiently. The NAD+/NADH ratio shifts, further impairing glucose production. The liver can only process about one standard drink per hour, so the more you drink, the longer this suppression lasts."
            },
            {
              heading: "The Timeline of Risk",
              text: "Understanding when lows are most likely helps with prevention. 0-2 hours: Carbs from alcoholic beverages may cause a spike. You're still eating and attentive. 2-4 hours: Mixed picture—initial carb effects wearing off, liver suppression beginning. 4-8 hours: Peak danger zone for many people. Liver fully occupied, glucose stores depleted, often sleeping. 8-12 hours: Risk continues, especially if drinking was heavy. Glycogen stores still depleted. 12-24 hours: Gradual return to normal. May have increased insulin sensitivity."
            },
            {
              heading: "Why Glucagon May Not Work",
              text: "Glucagon, the rescue medication for severe hypoglycemia, works by signaling the liver to release glucose. When the liver is occupied with alcohol metabolism, its response to glucagon is impaired. This is why: Glucagon may work more slowly or not at all during heavy drinking. Dextrose/glucose (oral or IV) is more reliable. Prevention is especially important when drinking because your safety net is compromised."
            },
            {
              heading: "Evidence-Based Prevention Strategies",
              text: "Based on the biochemistry: Reduce basal insulin: 20-30% reduction starting before drinking, continuing 8-12 hours after last drink. Eat before bed: Slow-digesting foods (protein, fat) provide sustained glucose. Avoid peak insulin timing: Don't drink when you have significant bolus insulin active. Check overnight: Set a 3am alarm, or rely on CGM with high-priority alerts. Restore glycogen: Eat a carb-containing breakfast even if not hungry. Know your limits: Moderate drinking is much safer than heavy drinking from a blood sugar perspective."
            }
          ],
          medical_disclaimer: "This article is for educational purposes. Individual responses vary. Work with your endocrinologist to develop a personalized alcohol management plan."
        },
        featured_image_url: "https://images.unsplash.com/photo-1582213782179-e0d53f98f2ca?w=800",
        category: "18+ Content",
        tags: ["alcohol", "hypoglycemia", "science", "liver", "prevention"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 13,
        views: 2543,
        published_at: "2024-08-15T10:00:00Z"
      },

      // RESEARCH CATEGORY (5)
      {
        title: "Understanding the Latest Cure Research: 2024-2025 Update",
        slug: "cure-research-update-2024-2025",
        excerpt: "A comprehensive look at the most promising Type 1 diabetes cure approaches currently in development.",
        content: {
          sections: [
            {
              heading: "The State of Cure Research in 2025",
              text: "After decades of 'five years away' predictions, cure research for Type 1 diabetes has reached an unprecedented level of sophistication. Multiple approaches are now in Phase 2 and Phase 3 clinical trials, with several potential therapies on the path to FDA approval. This article examines the leading candidates and their realistic timelines."
            },
            {
              heading: "Cell Replacement Therapies",
              text: "Vertex Pharmaceuticals' VX-880 and VX-264 represent the furthest-along stem cell approaches. VX-880 uses encapsulated stem cell-derived beta cells that require immunosuppression. Early trial results showed patients achieving insulin independence. VX-264 uses an encapsulation device to eliminate the need for immunosuppression. Both are in Phase 2 trials with potential approval timelines of 2026-2027 for VX-880."
            },
            {
              heading: "Immunotherapy Approaches",
              text: "Stopping the autoimmune attack is crucial for any lasting cure. Teplizumab (Tzield) is already FDA-approved for delaying T1D onset in high-risk individuals. Research continues on using similar approaches for those already diagnosed. Other immunotherapies target regulatory T-cells, trying to re-establish immune tolerance rather than simply suppressing immunity."
            },
            {
              heading: "Beta Cell Regeneration",
              text: "Rather than transplanting new cells, some research focuses on regenerating the body's own beta cells or converting other cells to produce insulin. GLP-1 agonists (already approved for Type 2) show some beta cell protective effects. Verapamil, a blood pressure medication, has shown ability to preserve beta cell function in newly diagnosed patients."
            },
            {
              heading: "Realistic Timeline Assessment",
              text: "Based on current trial stages: 2025-2026: Potential approval of more immunotherapy approaches for prevention. 2026-2028: First stem cell therapies may receive approval for limited patient populations. 2028-2030: Encapsulation technologies may eliminate need for immunosuppression. 2030+: Potential for widely accessible functional cures. Important note: 'Cure' may initially mean insulin independence with ongoing medication, not complete elimination of the condition."
            }
          ],
          medical_disclaimer: "This article discusses experimental treatments in clinical trials. Results may not reflect final outcomes. Consult with healthcare providers about treatment options."
        },
        featured_image_url: "https://images.unsplash.com/photo-1579165466949-3180a3d056d5?w=800",
        category: "Research",
        tags: ["cure", "stem cells", "immunotherapy", "clinical trials"],
        is_published: true,
        is_featured: true,
        reading_time_mins: 14,
        views: 8923,
        published_at: "2025-01-10T10:00:00Z"
      },
      {
        title: "How CGM Technology Has Evolved: A Timeline",
        slug: "cgm-technology-evolution-timeline",
        excerpt: "From the first continuous glucose monitors to today's sophisticated systems, the technology has transformed diabetes management.",
        content: {
          sections: [
            {
              heading: "The Pre-CGM Era",
              text: "Before continuous glucose monitoring, people with diabetes relied on fingerstick blood glucose tests. The first home glucose meter, the Ames Reflectance Meter, appeared in 1971. By the 1990s, meters had become portable and relatively affordable, but they only provided snapshots—no trend data, no alarms, and testing required active effort multiple times daily."
            },
            {
              heading: "First Generation: 1999-2005",
              text: "The FDA approved the first CGM, the MiniMed CGMS, in 1999. It was worn for 3 days, and data could only be downloaded and reviewed by a doctor afterward—no real-time data for patients. Accuracy was limited, and sensors were uncomfortable. Few insurance plans covered the technology, and adoption remained low."
            },
            {
              heading: "Second Generation: 2006-2015",
              text: "The Dexcom STS and Medtronic Guardian REAL-Time brought real-time data to patients. Sensors improved in accuracy and comfort. The MARD (mean absolute relative difference) metric became standard—lower numbers mean more accuracy. During this era, MARD values ranged from 15-20%, meaning readings could be off by that percentage from true blood sugar."
            },
            {
              heading: "Third Generation: 2016-2020",
              text: "The Dexcom G5 and G6, Abbott FreeStyle Libre, and Medtronic Guardian 3 represented major advances. Factory calibration eliminated fingersticks for some systems. Smartphone connectivity became standard. MARD values dropped to 9-11%. Extended wear times (10-14 days) improved convenience. Integration with insulin pumps enabled automated insulin delivery systems."
            },
            {
              heading: "Current Generation: 2021-Present",
              text: "Today's CGMs represent a quantum leap. Dexcom G7, FreeStyle Libre 3, and Medtronic Guardian 4 are smaller than ever. MARD values approaching 8% rival lab accuracy. Extended wear times, faster warmup, and improved adhesives enhance user experience. Integration with smartwatches provides glance-able data. Machine learning predicts trends hours in advance."
            },
            {
              heading: "The Future",
              text: "Emerging technologies include: Non-invasive CGM using optical or electromagnetic sensing—multiple companies are in development. Implantable sensors lasting 6+ months, reducing insertion burden. AI-powered trend prediction for more proactive management. Direct integration with insulin delivery for fully closed-loop 'artificial pancreas' systems."
            }
          ],
          medical_disclaimer: "This historical article is for educational purposes. Device selection should be discussed with your healthcare provider."
        },
        featured_image_url: "https://images.unsplash.com/photo-1576091160399-112ba8d25d1f?w=800",
        category: "Research",
        tags: ["CGM", "technology", "history", "Dexcom", "Libre"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 11,
        views: 5432,
        published_at: "2024-11-05T10:00:00Z"
      },
      {
        title: "Immunotherapy for T1D: Current Clinical Trials",
        slug: "immunotherapy-t1d-clinical-trials",
        excerpt: "Examining the immunotherapy approaches being tested to prevent or reverse Type 1 diabetes autoimmunity.",
        content: {
          sections: [
            {
              heading: "The Autoimmune Problem",
              text: "Type 1 diabetes occurs when the immune system mistakenly attacks and destroys insulin-producing beta cells. This autoimmune destruction typically happens over months to years before diagnosis. Immunotherapy aims to stop this attack, either preventing T1D in high-risk individuals or preserving remaining beta cells in those recently diagnosed."
            },
            {
              heading: "Teplizumab (Tzield)",
              text: "The first FDA-approved immunotherapy for T1D, Tzield, is an anti-CD3 monoclonal antibody. Approved in 2022 for delaying T1D onset in high-risk individuals. In trials, it delayed onset by a median of 2-3 years. A 14-day infusion course modifies T-cell behavior. Research continues on using it in newly diagnosed patients to preserve remaining beta cells."
            },
            {
              heading: "Abatacept and CTLA4-Ig",
              text: "Abatacept blocks co-stimulatory signals needed for T-cell activation. The TREATM trial showed it preserved C-peptide (a marker of beta cell function) in newly diagnosed patients. Effects were modest but significant. Monthly infusions required during treatment period."
            },
            {
              heading: "Low-Dose IL-2",
              text: "Interleukin-2 is a signaling molecule that supports regulatory T-cells (Tregs), which suppress autoimmune responses. Low doses may boost Tregs without activating effector T-cells that attack beta cells. Multiple trials are ongoing with different dosing regimens."
            },
            {
              heading: "Combination Approaches",
              text: "Researchers increasingly believe that combining approaches may be more effective. Anti-CD3 + beta cell antigen-specific therapy to induce tolerance. Immunotherapy + beta cell regeneration to both stop attack and restore cells. Multiple targets at different stages of the immune response."
            },
            {
              heading: "How to Participate in Trials",
              text: "ClinicalTrials.gov lists current studies. TRIALNET screens family members of T1D patients for high-risk markers. Many academic medical centers run prevention trials. Newly diagnosed patients are particularly sought for preservation studies. Participation contributes to science even if a particular treatment doesn't work."
            }
          ],
          medical_disclaimer: "Clinical trials involve experimental treatments with unknown risks and benefits. Participation should be carefully considered with healthcare providers."
        },
        featured_image_url: "https://images.unsplash.com/photo-1532187863486-abf9dbad1b69?w=800",
        category: "Research",
        tags: ["immunotherapy", "clinical trials", "Teplizumab", "prevention"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 12,
        views: 4123,
        published_at: "2024-12-01T10:00:00Z"
      },
      {
        title: "The Microbiome Connection to Type 1 Diabetes",
        slug: "microbiome-type-1-diabetes",
        excerpt: "Exploring the emerging science linking gut bacteria to autoimmune diabetes development and prevention.",
        content: {
          sections: [
            {
              heading: "The Gut-Immune Connection",
              text: "The gut microbiome—the trillions of bacteria living in our intestines—plays a crucial role in immune system development. About 70% of immune cells reside in gut-associated lymphoid tissue. This means the bacteria we harbor directly influence how our immune system learns what to attack and what to tolerate."
            },
            {
              heading: "Evidence Linking Microbiome to T1D",
              text: "Multiple studies have found microbiome differences in people who develop T1D: The TEDDY study followed thousands of children from birth and found reduced bacterial diversity before T1D onset. The DIABIMMUNE study showed that children in Finland (high T1D rates) had different gut bacteria than children in Russian Karelia (lower rates), despite similar genetics. Specific bacteria (like Bacteroides species) have been associated with increased or decreased T1D risk."
            },
            {
              heading: "Proposed Mechanisms",
              text: "How might gut bacteria influence T1D development? Leaky gut: Some bacteria promote intestinal permeability, allowing proteins to enter the bloodstream and trigger immune responses. Molecular mimicry: Bacterial proteins may resemble beta cell proteins, confusing the immune system. Short-chain fatty acids: Beneficial bacteria produce compounds that regulate immune tolerance. Early-life immune education: Gut bacteria help 'train' the developing immune system."
            },
            {
              heading: "Interventions Being Studied",
              text: "Probiotics: Specific strains like Lactobacillus and Bifidobacterium are being tested for immune-modulating effects. Prebiotics: Feeding beneficial bacteria with fiber may shift the microbiome favorably. Fecal microbiota transplant: Early research is exploring whether transplanting healthy gut bacteria could prevent or treat autoimmunity. Dietary patterns: Mediterranean and high-fiber diets promote beneficial microbiome profiles."
            },
            {
              heading: "What This Means Now",
              text: "While research is promising, no microbiome-based T1D prevention has been proven yet. Current recommendations: Avoid unnecessary antibiotics, especially in early childhood. Breastfeeding supports healthy microbiome development. A diverse, fiber-rich diet promotes beneficial bacteria. Research participation helps advance the field."
            }
          ],
          medical_disclaimer: "Microbiome research is still developing. Do not make treatment decisions based on preliminary findings without consulting healthcare providers."
        },
        featured_image_url: "https://images.unsplash.com/photo-1578496479914-7ef3b0193be3?w=800",
        category: "Research",
        tags: ["microbiome", "gut health", "prevention", "immunology"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 10,
        views: 3245,
        published_at: "2024-10-12T10:00:00Z"
      },
      {
        title: "Beta Cell Regeneration: Current State of Science",
        slug: "beta-cell-regeneration-science",
        excerpt: "Can we regrow the insulin-producing cells destroyed by Type 1 diabetes? Here's where the research stands.",
        content: {
          sections: [
            {
              heading: "The Regeneration Challenge",
              text: "Unlike some organs that regenerate readily (like the liver), beta cells have very limited regenerative capacity in adults. By the time of T1D diagnosis, 70-90% of beta cells have been destroyed. Any regeneration approach must also address the ongoing autoimmune attack—otherwise new cells would simply be destroyed as well."
            },
            {
              heading: "Endogenous Beta Cell Replication",
              text: "Some research focuses on stimulating remaining beta cells to divide. The harmine compound stimulates beta cell proliferation in lab studies. GLP-1 receptor agonists (like semaglutide) have shown beta cell protective effects. Challenges include achieving clinically meaningful increases and preventing exhaustion of remaining cells."
            },
            {
              heading: "Transdifferentiation",
              text: "This approach converts other cell types into insulin-producing cells. Alpha cells (which make glucagon) are closely related to beta cells and can be converted. Liver cells and intestinal cells have also been converted in laboratory settings. The advantage is using the patient's own cells; the challenge is doing this safely in living humans."
            },
            {
              heading: "Stem Cell-Derived Beta Cells",
              text: "Multiple companies are working on creating beta cells from stem cells. Vertex's VX-880 uses embryonic stem cell-derived beta cells. Other approaches use induced pluripotent stem cells (iPSCs) from the patient themselves. Major advances have made lab-grown beta cells function nearly as well as natural ones."
            },
            {
              heading: "Drug Repurposing Discoveries",
              text: "Verapamil, a blood pressure medication, was shown to preserve beta cell mass in newly diagnosed patients (FADES trial). The drug reduces oxidative stress in beta cells, promoting survival. This represents one of the few available interventions for recent-onset T1D. Additional medications are being screened for similar effects."
            },
            {
              heading: "The Path Forward",
              text: "A functional cure will likely combine: Regeneration or replacement of beta cells, Protection from ongoing autoimmune attack, Methods to maintain long-term cell function. The most promising approach is likely stem cell-derived cells with immune protection, either through encapsulation or gene editing to make cells invisible to the immune system."
            }
          ],
          medical_disclaimer: "Beta cell regeneration is an active research area. No regeneration therapies are currently approved for T1D treatment."
        },
        featured_image_url: "https://images.unsplash.com/photo-1559757175-5700dde675bc?w=800",
        category: "Research",
        tags: ["beta cells", "regeneration", "stem cells", "research"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 13,
        views: 4567,
        published_at: "2024-09-28T10:00:00Z"
      },

      // LIFESTYLE CATEGORY (5)
      {
        title: "Exercise and T1D: The Complete Guide",
        slug: "exercise-type-1-diabetes-complete-guide",
        excerpt: "From cardio to strength training, learn how to exercise safely and effectively with Type 1 diabetes.",
        content: {
          sections: [
            {
              heading: "Why Exercise Matters for T1D",
              text: "Regular physical activity provides enormous benefits for people with Type 1 diabetes: improved insulin sensitivity, better cardiovascular health, weight management, mental health benefits, and improved A1C levels. However, exercise also adds complexity to blood sugar management. Understanding how different activities affect glucose is key to exercising safely."
            },
            {
              heading: "Aerobic vs. Anaerobic: Different Effects",
              text: "Aerobic exercise (running, swimming, cycling): Generally lowers blood sugar during and after activity. Muscles use glucose for energy, and insulin sensitivity increases. Effect can last 24+ hours. Anaerobic exercise (weight lifting, sprinting, HIIT): May initially raise blood sugar due to adrenaline and glucose release from the liver. Blood sugar often drops later as muscles replenish glycogen. Many workouts combine both—understanding which predominates helps with management."
            },
            {
              heading: "Pre-Exercise Preparation",
              text: "Before starting: Check blood sugar and trend arrows on CGM. Ideal starting range varies but 120-180mg/dL is commonly targeted. Rising or stable arrows are better than falling arrows. Consider reducing bolus insulin 50-75% if eating within 2 hours before exercise. Some people reduce basal insulin 30-50% starting 1-2 hours before. Have glucose tabs, drinks, or snacks readily accessible."
            },
            {
              heading: "During Exercise Management",
              text: "Check glucose every 20-30 minutes during exercise, or use CGM continuous monitoring. For every 30 minutes of moderate exercise, you may need 15-30g carbs. Sports drinks can provide both fluid and carbs. Set CGM alerts higher during activity—you want warning before hitting dangerous lows. Recognize that CGM readings may lag behind actual blood sugar during rapid changes."
            },
            {
              heading: "Post-Exercise Considerations",
              text: "The 'lag effect' means blood sugar may continue dropping for hours after exercise. Consume carbs and protein within 30 minutes of finishing. Consider reducing basal insulin 10-20% for 6-8 hours after intense exercise. Nighttime lows are common after afternoon/evening workouts. Morning exercise tends to have less prolonged hypoglycemia risk."
            },
            {
              heading: "Sport-Specific Tips",
              text: "Running: Start at higher blood sugar (150-180), carry glucose, consider fuel belt. Swimming: Waterproof CGM essential, swimming can cause rapid drops, beach snacks ready. Weight lifting: Expect initial spike, then delayed drop. Team sports: Unpredictable duration/intensity makes planning harder—frequent checks essential."
            }
          ],
          medical_disclaimer: "Exercise recommendations should be individualized with your healthcare team, especially if you have diabetes complications."
        },
        featured_image_url: "https://images.unsplash.com/photo-1517836357463-d25dfeac3438?w=800",
        category: "Lifestyle",
        tags: ["exercise", "fitness", "sports", "cardio", "strength training"],
        is_published: true,
        is_featured: true,
        reading_time_mins: 15,
        views: 7234,
        published_at: "2024-12-20T10:00:00Z"
      },
      {
        title: "Travel Tips for Insulin-Dependent Diabetics",
        slug: "travel-tips-insulin-dependent-diabetics",
        excerpt: "Everything you need to know about traveling safely with diabetes, from airport security to time zone changes.",
        content: {
          sections: [
            {
              heading: "Before You Travel",
              text: "Get a letter from your doctor: Include diagnosis, list of medications and supplies, and statement that supplies must travel with you. Check TSA guidelines (or equivalent for your country). Know your destination's pharmacy and hospital locations. Get extra prescriptions filled—bring at least twice what you need. Research how to say 'I have diabetes' and 'I need sugar' in local language."
            },
            {
              heading: "Packing Supplies",
              text: "Always pack supplies in carry-on luggage—checked bags can be lost or exposed to temperature extremes. Bring: Double the insulin you need (separate vials in case of breakage), extra pump supplies, CGM sensors, glucose tabs and glucagon, backup glucose meter, batteries and chargers. Consider insulated cases for insulin if traveling to hot climates."
            },
            {
              heading: "Airport Security",
              text: "You can bring: Insulin, syringes, pens, pumps, CGMs, liquid glucose (4oz limit may not apply for medical liquids—declare them). Request hand inspection if you're concerned about X-rays (though they're generally safe for insulin). Tell agents about your pump—you can refuse full-body scanners if you prefer pat-down. Document everything in case of questions."
            },
            {
              heading: "Time Zone Changes",
              text: "Crossing time zones affects insulin timing: Traveling East (shorter day): You may need less basal insulin. Traveling West (longer day): You may need more basal insulin. General approach: Keep watch on home time until you adjust over 2-3 days. For pumps: Change clock gradually (2-3 hours per day). For injections: Adjust long-acting insulin timing incrementally. Check blood sugar more frequently during adjustment period."
            },
            {
              heading: "Managing Different Climates",
              text: "Heat: Insulin degrades above 86°F—use cooling cases, never leave in car. Cold: Insulin can freeze—keep close to body, not in outer pockets. Altitude: Some report increased insulin sensitivity at high altitude—check more often. Humidity: May affect CGM adhesion—bring extra patches and adhesive."
            },
            {
              heading: "Emergency Preparedness",
              text: "Know the local emergency number. Research local hospitals and pharmacies before you go. Carry diabetes ID in local language. Know insulin brand names in your destination (Humalog, NovoLog, etc. may have different names). Consider travel insurance that covers pre-existing conditions. Have a backup plan if you lose supplies—know how to get replacements."
            }
          ],
          medical_disclaimer: "Travel requirements vary by country and airline. Check current regulations before traveling."
        },
        featured_image_url: "https://images.unsplash.com/photo-1436491865332-7a61a109cc05?w=800",
        category: "Lifestyle",
        tags: ["travel", "flying", "vacation", "packing", "time zones"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 12,
        views: 5678,
        published_at: "2024-11-18T10:00:00Z"
      },
      {
        title: "Mental Health and Diabetes Burnout",
        slug: "mental-health-diabetes-burnout",
        excerpt: "Recognizing, understanding, and recovering from the emotional exhaustion of managing a chronic condition.",
        content: {
          sections: [
            {
              heading: "What is Diabetes Burnout?",
              text: "Diabetes burnout is a state of emotional exhaustion, frustration, and disengagement from diabetes management. It's not laziness or lack of knowledge—it's the result of managing a demanding condition 24/7 with no breaks, ever. Symptoms include: Feeling overwhelmed by diabetes tasks, Skipping blood sugar checks or boluses, Apathy about glucose numbers, Avoiding medical appointments, Guilt and frustration about management."
            },
            {
              heading: "The Mental Health-Diabetes Connection",
              text: "People with T1D have 2-3x higher rates of depression and anxiety compared to the general population. High blood sugars can cause mood changes and cognitive effects. Low blood sugars trigger stress hormones and fear responses. The constant vigilance required is mentally taxing. There's often grief about the life you imagined before diagnosis."
            },
            {
              heading: "Recognizing When You Need Help",
              text: "Warning signs that burnout is becoming dangerous: A1C rising significantly without clear cause, Frequent DKA or severe hypoglycemia, Actively avoiding all diabetes management, Thoughts of self-harm or not caring if you live, Unable to work or maintain relationships. These indicate it's time to seek professional help—not just willpower harder."
            },
            {
              heading: "Strategies for Recovery",
              text: "Reduce perfectionism: Aim for 'good enough' rather than perfect numbers. A realistic target range is more sustainable than an impossible one. Take micro-breaks: Even with constant management, find small ways to 'forget' about diabetes—hobbies, activities where it fades to background. Use technology: Let CGM and automated systems do some of the work. Seeking to reduce the mental load is valid. Connect with others: Diabetes communities (online or in-person) provide understanding that others can't offer."
            },
            {
              heading: "Professional Support Options",
              text: "Endocrinologists: Can adjust treatment to reduce complexity. Certified Diabetes Care and Education Specialists: Practical strategies and support. Therapists familiar with chronic illness: Processing emotions and developing coping strategies. Psychiatrists: When medication for depression or anxiety may help. Support groups: JDRF, Beyond Type 1, and local groups offer community."
            },
            {
              heading: "It's Not Your Fault",
              text: "Burnout is not a moral failing. It's a predictable response to an enormous, unrelenting burden. You deserve compassion—from yourself and others. Recovery is possible, and asking for help is a sign of strength."
            }
          ],
          medical_disclaimer: "If you're experiencing thoughts of self-harm, please contact a crisis helpline immediately. Mental health support is available."
        },
        featured_image_url: "https://images.unsplash.com/photo-1507003211169-0a1dd7228f2d?w=800",
        category: "Lifestyle",
        tags: ["mental health", "burnout", "depression", "anxiety", "support"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 11,
        views: 6789,
        published_at: "2024-10-25T10:00:00Z"
      },
      {
        title: "Pregnancy Planning with Type 1 Diabetes",
        slug: "pregnancy-planning-type-1-diabetes",
        excerpt: "What you need to know before, during, and after pregnancy with T1D for the healthiest outcomes.",
        content: {
          sections: [
            {
              heading: "Pre-Conception Planning is Essential",
              text: "Pregnancy with T1D requires careful planning. The first 8 weeks of pregnancy are crucial for fetal development—often before you know you're pregnant. Target A1C below 6.5% (ideally below 6%) for at least 3 months before conception. High blood sugars during early pregnancy significantly increase risks of birth defects, miscarriage, and complications."
            },
            {
              heading: "Working with Your Medical Team",
              text: "Before trying to conceive: Endocrinologist: Optimize diabetes management, review medications, adjust targets. Obstetrician or Maternal-Fetal Medicine specialist: Understand pregnancy risks, establish baseline assessments. Ophthalmologist: Retinopathy can worsen during pregnancy—get baseline exam. Potentially nephrologist and cardiologist if you have complications."
            },
            {
              heading: "Medication Considerations",
              text: "Some medications must be stopped before pregnancy: ACE inhibitors and ARBs (blood pressure). Statins (cholesterol). Some oral diabetes medications (though T1D typically uses insulin). Folic acid supplementation should begin at least 1 month before conception. Prenatal vitamins should be started early. Review all medications with your team."
            },
            {
              heading: "Managing Blood Sugar During Pregnancy",
              text: "Insulin needs change dramatically: First trimester: May have lower insulin needs and more hypoglycemia. Second trimester: Insulin resistance increases—needs may double. Third trimester: Peak insulin resistance—needs continue to rise. Post-delivery: Insulin needs drop dramatically and suddenly. Tight glucose targets are critical but hypoglycemia risk is also concerning. CGM is invaluable during pregnancy."
            },
            {
              heading: "Labor, Delivery, and Postpartum",
              text: "You may require IV insulin and glucose management during labor. C-section rates are higher but vaginal delivery is often possible. After delivery: Insulin needs drop 40-50% immediately—risk of severe lows. Breastfeeding is encouraged and safe but requires additional calorie intake. Blood sugar may be erratic as hormones stabilize."
            },
            {
              heading: "The Baby's Health",
              text: "With good glucose control, babies of T1D mothers have similar outcomes to other babies. Risks that remain slightly elevated include: Larger birth size (macrosomia), Low blood sugar after birth, Earlier delivery, NICU admission. These risks are significantly reduced with excellent blood sugar management before and during pregnancy."
            }
          ],
          medical_disclaimer: "Pregnancy with T1D should be managed by a specialized team. This article is for informational purposes only."
        },
        featured_image_url: "https://images.unsplash.com/photo-1493894473891-10fc1e5dbd22?w=800",
        category: "Lifestyle",
        tags: ["pregnancy", "family planning", "pre-conception", "maternal health"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 14,
        views: 4321,
        published_at: "2024-09-15T10:00:00Z"
      },
      {
        title: "Starting College with Type 1 Diabetes",
        slug: "starting-college-type-1-diabetes",
        excerpt: "A guide for students navigating independence, dorm life, and diabetes management away from home.",
        content: {
          sections: [
            {
              heading: "Before You Leave",
              text: "Preparation makes college with diabetes much smoother: Find an endocrinologist near campus—don't wait until you have a problem. Know your insurance coverage at school and where nearby pharmacies are. Stock up on supplies—campus mail can be unreliable. Register with disability services—they can provide testing accommodations and housing modifications. Connect with campus health services."
            },
            {
              heading: "Dorm Room Setup",
              text: "Create a diabetes-friendly space: Mini-fridge for insulin (verify with housing office—usually allowed for medical necessity). Glucose tabs on nightstand, in backpack, everywhere. Sharps container for used needles. Backup batteries and chargers for CGM. Snacks that don't require refrigeration. Make sure roommate knows about your diabetes and what to do in emergencies."
            },
            {
              heading: "Meal Plan Challenges",
              text: "Dining halls are challenging for carb counting: Portion sizes are hard to estimate with buffet-style. Ingredients aren't always labeled. Late-night dining options may be limited. Strategies: Take photos of portions and review after to learn. Ask dining staff about ingredients—food allergies have normalized this. Consider partial meal plan plus some independent cooking. Keep snacks in your room for when dining halls are closed."
            },
            {
              heading: "Social Life and Alcohol",
              text: "College often involves social drinking. Key points: Never drink alone—always have someone who knows about your diabetes. Alcohol on an empty stomach is especially dangerous with insulin. The 'college sleep schedule' can make overnight lows more dangerous. Set your CGM alerts to actually wake you. If you're going to drink, plan for delayed lows."
            },
            {
              heading: "Academic Accommodations",
              text: "You're entitled to reasonable accommodations under ADA: Testing in a separate room to check blood sugar. Extra time on exams if you experience a blood sugar issue. Ability to eat or drink during class/exams. Excused absences for medical appointments. Flexibility on deadlines during diabetes-related health issues. Register with disability services before you need accommodations."
            },
            {
              heading: "Building Your Independence",
              text: "College is an opportunity to take full ownership of your diabetes: You're the one scheduling appointments and refilling prescriptions. You decide when to check blood sugar (no parents reminding you). You manage your sleep, food, exercise, and stress. It's okay to struggle—most college students with T1D have an adjustment period. Find peer support through campus diabetes groups or online communities."
            }
          ],
          medical_disclaimer: "Talk to your healthcare team before making changes to your diabetes management routine. College transition is a good time for a care plan review."
        },
        featured_image_url: "https://images.unsplash.com/photo-1523050854058-8df90110c9f1?w=800",
        category: "Lifestyle",
        tags: ["college", "students", "independence", "dorm life"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 13,
        views: 3890,
        published_at: "2024-08-10T10:00:00Z"
      },

      // TECHNOLOGY CATEGORY (5)
      {
        title: "DIY Closed Loop Systems: An Overview",
        slug: "diy-closed-loop-systems-overview",
        excerpt: "Understanding Loop, OpenAPS, and Android APS—the community-developed automated insulin delivery systems.",
        content: {
          sections: [
            {
              heading: "What is a DIY Closed Loop?",
              text: "DIY closed loop systems are automated insulin delivery (AID) systems built by the diabetes community using open-source software. They combine insulin pumps, continuous glucose monitors, and algorithms running on phones or small computers to automatically adjust insulin delivery. They're called 'DIY' because users build and configure them themselves, rather than using FDA-approved commercial systems."
            },
            {
              heading: "The Major Systems",
              text: "Loop (iOS): Uses older Medtronic or Omnipod pumps with iPhone app. Developed by a community of T1D parents and engineers. Requires programming skills for initial setup. OpenAPS: Original DIY system, runs on Raspberry Pi or similar. Works with older Medtronic pumps. Algorithm is well-documented and trusted. Android APS: Runs on Android phones. Compatible with various pumps including DANA. Highly configurable with many safety features. iAPS: Newer iOS option with updated algorithms. Works with Omnipod Dash and other pumps."
            },
            {
              heading: "Benefits vs. Commercial Systems",
              text: "DIY systems often outperform commercial options: More aggressive and customizable algorithms. Faster updates as community improves software. No wait for FDA approval of improvements. Remote monitoring and control options. Predictive features not available commercially. However, they require technical skill, time investment, and accepting responsibility for a non-FDA-approved system."
            },
            {
              heading: "Risks and Considerations",
              text: "These are not FDA-approved devices—you take responsibility for outcomes. Requires significant technical setup and troubleshooting ability. Pump/CGM compatibility changes with firmware updates. You must understand the algorithm to use it safely. Hardware costs can be significant. Medical professionals may not support your choice."
            },
            {
              heading: "Getting Started",
              text: "If you're considering DIY: Spend time in community forums learning before building. Understand the algorithm concepts thoroughly. Start with conservative settings and adjust slowly. Have backup supplies and plans for system failures. Connect with experienced DIY loopers for support. Document your setup and settings carefully."
            },
            {
              heading: "The Future of DIY",
              text: "Commercial systems are gradually incorporating features pioneered by DIY. Tidepool Loop is working toward FDA approval of an open-source system. The DIY community continues to innovate faster than commercial development. Many endocrinologists are becoming more supportive as outcomes data accumulates."
            }
          ],
          medical_disclaimer: "DIY closed loop systems are not FDA-approved. Using them is at your own risk. This article is for educational purposes only."
        },
        featured_image_url: "https://images.unsplash.com/photo-1518770660439-4636190af475?w=800",
        category: "Technology",
        tags: ["DIY", "Loop", "OpenAPS", "closed loop", "AID"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 14,
        views: 5678,
        published_at: "2024-12-05T10:00:00Z"
      },
      {
        title: "Choosing Your First Insulin Pump",
        slug: "choosing-first-insulin-pump",
        excerpt: "A comprehensive comparison of current insulin pump options to help you make the right choice.",
        content: {
          sections: [
            {
              heading: "Why Consider a Pump?",
              text: "Insulin pumps offer advantages over multiple daily injections (MDI): Precise basal rate adjustment throughout the day. Easy bolusing without injections. Better management of dawn phenomenon and exercise. Foundation for automated insulin delivery. Reduced A1C for many users. However, pumps also require: Wearing a device 24/7, learning new technology, managing supplies, and more frequent site changes."
            },
            {
              heading: "Tubed vs. Tubeless",
              text: "Tubed pumps (Medtronic, Tandem): Pump unit separate from body, connected by thin tubing. Infusion sets can be placed in more locations. Battery/reservoir replaceable without removing from body. May snag on objects. Tubeless pumps (Omnipod): All-in-one pod adheres directly to body. No tubing to manage. Must replace entire pod every 3 days. Fewer infusion site options."
            },
            {
              heading: "Current Major Options (2025)",
              text: "Tandem t:slim X2: Touchscreen interface, Control-IQ automation with Dexcom, sleek design. Medtronic 780G: Most established brand, Guardian 4 CGM integration, Auto Mode automation. Omnipod 5: Tubeless, Dexcom integration, automated delivery. BETA BIONICS iLet: Simplest automation—only enters carbs, no manual bolusing. Insulin-only and bihormonal options. Consider CGM compatibility, insurance coverage, and your lifestyle."
            },
            {
              heading: "Questions to Ask Yourself",
              text: "How important is discretion? (Tubeless may be more discreet). Do you want maximum automation or prefer more control? What CGM do you use or plan to use? What's your insurance coverage for each option? How comfortable are you with technology? Do you want smartphone control? How active is your lifestyle (sports, swimming)?"
            },
            {
              heading: "The Trial Process",
              text: "Most pump companies offer demos and trial periods. Certified Diabetes Educators can show you options. Connect with pump users online to ask real-world questions. Your endo should support your choice but you have the final say. Consider backup plans—what if you hate the pump?"
            },
            {
              heading: "Making the Transition",
              text: "Expect a learning curve of 2-4 weeks. Start with settings similar to your MDI regimen. Work closely with your endo or CDE on initial programming. Many people see temporary worsening before improvement. Give it at least 3 months before deciding if pumping is for you."
            }
          ],
          medical_disclaimer: "Insulin pump selection should be discussed with your healthcare team based on your individual needs."
        },
        featured_image_url: "https://images.unsplash.com/photo-1576091160399-112ba8d25d1f?w=800",
        category: "Technology",
        tags: ["insulin pump", "Tandem", "Medtronic", "Omnipod", "comparison"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 12,
        views: 6234,
        published_at: "2024-11-10T10:00:00Z"
      },
      {
        title: "CGM Accuracy: Comparing the Latest Models",
        slug: "cgm-accuracy-comparing-latest-models",
        excerpt: "Breaking down the accuracy specifications and real-world performance of current CGM systems.",
        content: {
          sections: [
            {
              heading: "Understanding CGM Accuracy Metrics",
              text: "MARD (Mean Absolute Relative Difference) is the primary accuracy measure. It represents the average percentage difference between CGM readings and lab reference values. A 10% MARD means readings are, on average, within 10% of actual blood sugar. Lower MARD is better, but the number alone doesn't tell the whole story—accuracy varies based on glucose level, rate of change, and other factors."
            },
            {
              heading: "Dexcom G7",
              text: "MARD: 8.2% overall. Warmup time: 30 minutes (fastest available). Sensor life: 10 days. Notable features: Smallest sensor size, direct Apple Watch app, 12-hour grace period. Real-world performance: Excellent accuracy, occasional compression lows, strong integration ecosystem. Best for: Users wanting tight integration with pumps and maximum app options."
            },
            {
              heading: "FreeStyle Libre 3",
              text: "MARD: 7.9% overall. Warmup time: 60 minutes. Sensor life: 14 days. Notable features: Smallest sensor ever, optional alarms, very affordable. Real-world performance: Excellent steady-state accuracy, may lag during rapid changes. Best for: Users prioritizing sensor size, cost, or longer wear time."
            },
            {
              heading: "Medtronic Guardian 4",
              text: "MARD: 8.7% overall. Warmup time: 2 hours. Sensor life: 7 days. Notable features: Best with Medtronic pumps, calibration optional, Auto Mode integration. Real-world performance: Solid accuracy, integrated system benefits, shorter sensor life. Best for: Medtronic pump users wanting seamless integration."
            },
            {
              heading: "Real-World Accuracy Factors",
              text: "Published MARD values come from controlled studies. Real-world accuracy is affected by: Hydration status (dehydration worsens accuracy). Sensor age (first and last days often less accurate). Compression (sleeping on sensor causes false lows). Rate of change (CGMs lag behind rapid changes by 5-15 minutes). Skin preparation and adhesion quality. Individual physiological differences."
            },
            {
              heading: "Making Your Choice",
              text: "Accuracy differences between top CGMs are clinically minimal for most users. More important factors: Pump compatibility if you use one, sensor size preferences, wear duration, cost/insurance coverage, app ecosystem and data sharing. Try different systems if possible—personal preference matters more than small accuracy differences."
            }
          ],
          medical_disclaimer: "CGM selection should be discussed with your healthcare provider. Accuracy specifications are from manufacturer data."
        },
        featured_image_url: "https://images.unsplash.com/photo-1576091160399-112ba8d25d1f?w=800",
        category: "Technology",
        tags: ["CGM", "Dexcom", "Libre", "Guardian", "accuracy"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 11,
        views: 5123,
        published_at: "2024-10-18T10:00:00Z"
      },
      {
        title: "Smart Insulin Pens: Are They Worth It?",
        slug: "smart-insulin-pens-worth-it",
        excerpt: "Evaluating the benefits and costs of connected insulin pens for those on MDI therapy.",
        content: {
          sections: [
            {
              heading: "What Are Smart Insulin Pens?",
              text: "Smart insulin pens are reusable or connected pen devices that track insulin doses, timing, and sometimes pair with apps and CGMs. They bridge the gap between traditional MDI and pumps, offering some automation benefits without the commitment of wearing a pump. Major options include InPen, Tempo Pen, and NovoPen 6/Echo Plus."
            },
            {
              heading: "Key Features",
              text: "Dose tracking: Records every injection with timestamp and amount. Insulin on board (IOB): Calculates active insulin to prevent stacking. Dose calculators: Recommend boluses based on carbs, blood sugar, and IOB. CGM integration: Some connect with Dexcom or Libre for unified data. App connectivity: Data syncs to smartphone apps. Sharing: Some allow healthcare providers or caregivers to view data."
            },
            {
              heading: "InPen (Medtronic)",
              text: "Works with any 3mL cartridge insulin. Full dose calculator with customizable settings. Dexcom G6/G7 integration. Detailed reports for endo appointments. Requires pen replacement annually. Cost: Pen is prescription but often covered; compatible insulin not included."
            },
            {
              heading: "NovoPen 6/Echo Plus",
              text: "Works only with Novo Nordisk insulins. Tracks doses but no built-in calculator. Connects to Libre 2+ via LibreView. Echo Plus shows last dose on pen display. Long battery life (5+ years). More basic than InPen but simpler."
            },
            {
              heading: "Benefits vs. Traditional Pens",
              text: "Reduced dose stacking errors (knowing when you last injected). Better data for adjusting regimens with your endo. Carb counting and dose calculation help. Confidence for newer T1Ds or caregivers. More engagement with diabetes data. Can be stepping stone to pump or preferred alternative."
            },
            {
              heading: "Are They Worth It?",
              text: "Smart pens make most sense if: You frequently forget doses or amounts. You want better data without switching to a pump. You're new to T1D and still learning dosing. You have caregivers who need visibility. They may not be worth it if: You rarely miss or stack doses. You prefer minimal technology. Cost isn't covered by insurance. You're likely to switch to a pump soon."
            }
          ],
          medical_disclaimer: "Discuss insulin delivery options with your healthcare provider to determine what's best for your needs."
        },
        featured_image_url: "https://images.unsplash.com/photo-1576091160399-112ba8d25d1f?w=800",
        category: "Technology",
        tags: ["smart pen", "InPen", "NovoPen", "MDI", "technology"],
        is_published: true,
        is_featured: false,
        reading_time_mins: 10,
        views: 3456,
        published_at: "2024-09-05T10:00:00Z"
      },
      {
        title: "The Future of Artificial Pancreas Systems",
        slug: "future-artificial-pancreas-systems",
        excerpt: "What's coming next in automated insulin delivery technology over the next 5-10 years.",
        content: {
          sections: [
            {
              heading: "Where We Are Today",
              text: "Current 'artificial pancreas' systems (also called hybrid closed-loop or automated insulin delivery systems) have transformed diabetes management. Control-IQ, 780G, Omnipod 5, and others automatically adjust basal insulin based on CGM readings and can give automatic corrections. However, they still require: Announcing meals and bolusing for carbs, changing infusion sets and CGM sensors, dealing with pump failures and site issues, significant user input and oversight."
            },
            {
              heading: "Fully Closed Loop",
              text: "The next major step is eliminating the need to announce meals. Beta Bionics' iLet already minimizes user input (only enter carb grams). True fully closed loop would require: Faster-acting insulin formulations. Better CGM accuracy during rapid changes. More sophisticated algorithms that detect and respond to meals. This may arrive in the next 3-5 years for select patient populations."
            },
            {
              heading: "Dual Hormone Systems",
              text: "Adding glucagon (or glucagon analogues) to insulin-only systems could dramatically improve outcomes. Glucagon can prevent lows by raising blood sugar. Beta Bionics has a bihormonal version of iLet in development. Challenges include glucagon stability, cost, and regulatory approval. Dual hormone systems may be the key to truly safe fully closed loop operation."
            },
            {
              heading: "Next-Generation CGMs",
              text: "CGM improvements will enable better automation: Non-invasive CGMs using optical or electromagnetic sensing are in development (though none are accurate enough yet). Implantable sensors lasting 6+ months would reduce burden. Faster response time would allow tighter control. Multi-analyte sensors measuring more than just glucose (ketones, lactate) could improve safety."
            },
            {
              heading: "Smaller, Simpler Hardware",
              text: "Device miniaturization continues: Thinner, smaller insulin pumps approaching 'patch pump' simplicity. CGMs that are virtually invisible. Potential for all-in-one pump/CGM patches. Integration with smartwatches for control and display. Goal is to make diabetes technology 'invisible' in daily life."
            },
            {
              heading: "The Role of AI",
              text: "Machine learning is already improving algorithms. Future applications include: Personalized algorithms that learn your patterns. Predictive features that anticipate problems hours in advance. Automatic adjustments for exercise, stress, illness. Integration with other health data (sleep, activity, meals). AI won't replace user judgment but will reduce the mental burden of diabetes management."
            }
          ],
          medical_disclaimer: "Future technologies described are in development and may not become available as described. Current treatment should be discussed with your healthcare provider."
        },
        featured_image_url: "https://images.unsplash.com/photo-1485827404703-89b55fcc595e?w=800",
        category: "Technology",
        tags: ["artificial pancreas", "closed loop", "future", "AI", "automation"],
        is_published: true,
        is_featured: true,
        reading_time_mins: 15,
        views: 7890,
        published_at: "2025-01-05T10:00:00Z"
      }
    ];

    // Insert articles
    const { data, error } = await supabase
      .from('articles')
      .upsert(articles, { onConflict: 'slug' });

    if (error) {
      console.error('Error seeding articles:', error);
      throw error;
    }

    const categories = articles.reduce((acc, article) => {
      const cat = article.category || 'Uncategorized';
      acc[cat] = (acc[cat] || 0) + 1;
      return acc;
    }, {} as Record<string, number>);

    console.log(`Successfully seeded ${articles.length} articles`);

    return new Response(
      JSON.stringify({ 
        success: true, 
        message: `Seeded ${articles.length} articles`,
        categories
      }),
      { headers: { ...corsHeaders, 'Content-Type': 'application/json' } }
    );

  } catch (error: unknown) {
    console.error('Error in seed-articles:', error);
    return new Response(
      JSON.stringify({ error: error instanceof Error ? error.message : 'Unknown error' }),
      { status: 500, headers: { ...corsHeaders, 'Content-Type': 'application/json' } }
    );
  }
});
